Literature DB >> 27220370

Feasibility of a Team Approach to Complex Congenital Heart Defect Neurodevelopmental Follow-Up: Early Experience of a Combined Cardiology/Neonatal Intensive Care Unit Follow-Up Program.

Olena Chorna1, H Scott Baldwin1, Jamie Neumaier1, Shirley Gogliotti1, Deborah Powers1, Amanda Mouvery1, David Bichell1, Nathalie L Maitre2.   

Abstract

Infants with complex congenital heart disease are at high risk for poor neurodevelopmental outcomes. However, implementation of dedicated congenital heart disease follow-up programs presents important infrastructure, personnel, and resource challenges. We present the development, implementation, and retrospective review of 1- and 2-year outcomes of a Complex Congenital Heart Defect Neurodevelopmental Follow-Up program. This program was a synergistic approach between the Pediatric Cardiology, Cardiothoracic Surgery, Pediatric Intensive Care, and Neonatal Intensive Care Unit Follow-Up teams to provide a feasible and responsible utilization of existing infrastructure and personnel, to develop and implement a program dedicated to children with congenital heart disease. Trained developmental testers administered the Ages and Stages Questionnaire-3 over the phone to the parents of all referred children at least once between 6 and 12 months' corrected age. At 18 months' corrected age, all children were scheduled in the Neonatal Intensive-Care Unit Follow-Up Clinic for a visit with standardized neurological exams, Bayley III, multidisciplinary therapy evaluations and continued follow-up. Of the 132 patients identified in the Cardiothoracic Surgery database and at discharge from the hospital, a total number of 106 infants were reviewed. A genetic syndrome was identified in 23.4% of the population. Neuroimaging abnormalities were identified in 21.7% of the cohort with 12.8% having visibly severe insults. As a result, 23 (26.7%) received first-time referrals for early intervention services, 16 (13.8%) received referrals for new services in addition to their existing ones. We concluded that utilization of existing resources in collaboration with established programs can ensure targeted neurodevelopmental follow-up for all children with complex congenital heart disease.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  heart defects, congenital; intensive care units, neonatal; neuroimaging; neurologic examination; referral and consultation

Mesh:

Year:  2016        PMID: 27220370      PMCID: PMC5285512          DOI: 10.1161/CIRCOUTCOMES.116.002614

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  21 in total

1.  Current state of high-risk infant follow-up care in the United States: results of a national survey of academic follow-up programs.

Authors:  V S Kuppala; M Tabangin; B Haberman; J Steichen; K Yolton
Journal:  J Perinatol       Date:  2011-07-14       Impact factor: 2.521

2.  Cardiology patient page. Neurodevelopmental outcomes in congenital heart disease.

Authors:  Caitlin K Rollins; Jane W Newburger
Journal:  Circulation       Date:  2014-09-30       Impact factor: 29.690

3.  Definition and classification of cerebral palsy: a historical perspective.

Authors:  Christopher Morris
Journal:  Dev Med Child Neurol Suppl       Date:  2007-02

4.  Variation in outcomes for risk-stratified pediatric cardiac surgical operations: an analysis of the STS Congenital Heart Surgery Database.

Authors:  Jeffrey Phillip Jacobs; Sean M O'Brien; Sara K Pasquali; Marshall Lewis Jacobs; François G Lacour-Gayet; Christo I Tchervenkov; Erle H Austin; Christian Pizarro; Kamal K Pourmoghadam; Frank G Scholl; Karl F Welke; J William Gaynor; David R Clarke; John E Mayer; Constantine Mavroudis
Journal:  Ann Thorac Surg       Date:  2012-06-15       Impact factor: 4.330

5.  Implementation of a routine developmental follow-up program for children with congenital heart disease: early results.

Authors:  Cheryl Brosig Soto; Olubunmi Olude; Raymond G Hoffmann; Laurel Bear; Ann Chin; Mahua Dasgupta; Kathleen Mussatto
Journal:  Congenit Heart Dis       Date:  2011-07-01       Impact factor: 2.007

6.  Predictive validity of the Bayley, Third Edition at 2 years for intelligence quotient at 4 years in preterm infants.

Authors:  Michelle M Bode; Diane B DʼEugenio; Barbara B Mettelman; Steven J Gross
Journal:  J Dev Behav Pediatr       Date:  2014 Nov-Dec       Impact factor: 2.225

7.  Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps.

Authors:  L A Papile; G Munsick-Bruno; A Schaefer
Journal:  J Pediatr       Date:  1983-08       Impact factor: 4.406

8.  Improved survival of patients undergoing palliation of hypoplastic left heart syndrome: lessons learned from 115 consecutive patients.

Authors:  James S Tweddell; George M Hoffman; Kathleen A Mussatto; Raymond T Fedderly; Stuart Berger; Robert D B Jaquiss; Nancy S Ghanayem; Stephanie J Frisbee; S Bert Litwin
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  A predictive model for neurodevelopmental outcome after the Norwood procedure.

Authors:  William T Mahle; Minmin Lu; Richard G Ohye; J William Gaynor; Caren S Goldberg; Lynn A Sleeper; Victoria L Pemberton; Kathleen A Mussatto; Ismee A Williams; Erica Sood; Catherine Dent Krawczeski; Alan Lewis; Nicole Mirarchi; Mark Scheurer; Sara K Pasquali; Nelangi Pinto; Jeffrey P Jacobs; Brian W McCrindle; Jane W Newburger
Journal:  Pediatr Cardiol       Date:  2012-08-03       Impact factor: 1.655

Review 10.  Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?

Authors:  Neil Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-10-10       Impact factor: 5.747

View more
  8 in total

Review 1.  Developmental Support for Infants With Genetic Disorders.

Authors:  Monica H Wojcik; Jane E Stewart; Susan E Waisbren; Jonathan S Litt
Journal:  Pediatrics       Date:  2020-05       Impact factor: 7.124

2.  Neurodevelopmental outcomes at 2 and 4 years in children with congenital heart disease.

Authors:  Cheryl L Brosig; Laurel Bear; Sydney Allen; Pippa Simpson; Liyun Zhang; Michele Frommelt; Kathleen A Mussatto
Journal:  Congenit Heart Dis       Date:  2018-09-06       Impact factor: 2.007

3.  Healthcare Disparities in Outcomes of a Metropolitan Congenital Heart Surgery Center: The Effect of Clinical and Socioeconomic Factors.

Authors:  Jennifer K Peterson; Kirsti G Catton; Shaun P Setty
Journal:  J Racial Ethn Health Disparities       Date:  2017-08-28

4.  Continuing Care For Critically Ill Children Beyond Hospital Discharge: Current State of Follow-up.

Authors:  Cydni N Williams; Trevor A Hall; Conall Francoeur; Jonathan Kurz; Lindsey Rasmussen; Mary E Hartman; Am Iqbal O'meara; Nikki Miller Ferguson; Ericka L Fink; Tracie Walker; Kurt Drury; Jessica L Carpenter; Jennifer Erklauer; Craig Press; Mark S Wainwright; Marlina Lovett; Heda Dapul; Sarah Murphy; Sarah Risen; Rejean M Guerriero; Alan Woodruff; Kristin P Guilliams
Journal:  Hosp Pediatr       Date:  2022-04-01

5.  The Benefits and Bias in Neurodevelopmental Evaluation for Children with Congenital Heart Disease.

Authors:  Kristi L Glotzbach; John J Ward; Jennifer Marietta; Aaron W Eckhauser; Sarah Winter; Michael D Puchalski; Thomas A Miller
Journal:  Pediatr Cardiol       Date:  2019-12-21       Impact factor: 1.655

Review 6.  Supporting Optimal Neurodevelopmental Outcomes in Infants and Children With Congenital Heart Disease.

Authors:  Jennifer K Peterson
Journal:  Crit Care Nurse       Date:  2018-06       Impact factor: 1.708

Review 7.  Transitions from short to long-term outcomes in pediatric critical care: considerations for clinical practice.

Authors:  Debbie A Long; Ericka L Fink
Journal:  Transl Pediatr       Date:  2021-10

8.  Predictors of Postoperative Rehabilitation Therapy Following Congenital Heart Surgery.

Authors:  Ana Ubeda Tikkanen; Meena Nathan; Lynn A Sleeper; Marisa Flavin; Ana Lewis; Donna Nimec; John E Mayer; Pedro Del Nido
Journal:  J Am Heart Assoc       Date:  2018-05-12       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.